ZEISS Group, founded in 1846 and headquartered in Oberkochen, Germany, is a global technology leader in optics and optoelectronics, renowned for its pioneering innovations in medical technology, semiconductor manufacturing, microscopy, and metrology. The company designs and manufactures a wide array of solutions including eyeglass lenses, camera lenses, binoculars, surgical microscopes, and lithography systems for chip production. ZEISS serves industries such as healthcare, life sciences, industrial quality assurance, and consumer electronics, with a strong focus on precision engineering, research partnerships, and sustainability. It operates in over 50 countries with a global workforce exceeding 35,000 employees.
The ZEISS PENTERO 800 S enhances deep anatomical work with ultra-high resolution 4K 3D exoscope views, optimizing team communication, ergonomics, and free movement for confident manipulation.
The extended partnership advances sub-2nm semiconductor R&D, enhances Europe's innovation leadership, supports imec’s pilot line, and aligns with the European Chips Act.
ZEISS Group's new R&D and manufacturing site in Suzhou Industrial Park officially opens, marking a milestone in ZEISS' efforts to further deepen its localization strategy in China.
ZEISS Medical Technology has announced the U.S. Food and Drug Administration (FDA) has cleared the QUATERA® 700*, a revolution in phaco technology. It includes the ZEISS patented QUATTRO Pump® which delivers an exceptional level of chamber stability independent of intra-ocular pressure (IOP) and flow.